Skip to main content

Advertisement

SpringerLink
Log in

Urinary metabolites identified using metabolomic analysis as potential biomarkers of nocturia in elderly men

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the association between nocturia and urinary metabolites in elderly men using metabolomic analysis.

Methods

We recruited 66 men aged 65–80 years. The 3-day frequency volume chart (FCV), International Prostate Symptom Score (IPSS), and quality of life score were used to assess micturition behavior. Participants with the total IPSS > 0 and ≥ 1.5 micturition on an average for three nights were included in the nocturia group. Participants with the total IPSS < 8 and < 1.5 micturition at night were included in the control group. We conducted a comprehensive metabolomic analysis of urine samples. Metabolites were compared between the groups using an unpaired t test. A multivariable logistic regression analysis was used to determine the relationship between nocturia and these metabolites.

Results

The nocturia and control groups consisted of 45 and 21 men, respectively. There were no differences in the background factors between the groups except for receiving anticholinergic drug and having life style-related diseases. The FVC revealed that nocturnal urine volume, 24 h micturition frequency, and nocturnal micturition frequency were significantly higher in the nocturia group than in the control group. The metabolomic analysis revealed 16 metabolites, which were differentially expressed between the groups. The multivariate analysis showed that increased serotonin level and decreased 3-hydroxypropionic acid and 3-indoleacetonitrile levels were associated with nocturia.

Conclusions

These findings suggest that abnormal urinary metabolites including serotonin, 3-hydroxypropionic acid, and 3-indoleacetonitrile are involved in the pathogenesis of nocturia in elderly men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Van Kerrebroeck P, Andersson KE (2014) Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn 33:S2–S5. https://doi.org/10.1002/nau.22595

    Article  PubMed  Google Scholar 

  2. Drake MJ (2015) Should nocturia not be called a lower urinary tract symptom? Eur Urol 67:289–290. https://doi.org/10.1016/j.eururo.2014.09.024

    Article  PubMed  Google Scholar 

  3. Kowalik CG, Cohn JA, Delpe S et al (2018) Nocturia: evaluation and current management strategies. Rev Urol 20:1–6. https://doi.org/10.3909/riu0797

    Article  PubMed  PubMed Central  Google Scholar 

  4. White L, Ma J, Liang S, Sanchez-Espiridion B, Liang D (2017) LC–MS/MS determination of d-mannose in human serum as a potential cancer biomarker. J Pharm Biomed Anal 137:54–59. https://doi.org/10.1016/j.jpba.2016.12.017

    Article  CAS  PubMed  Google Scholar 

  5. Robertson DG, Watkins PB, Reily MD (2011) Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci 120:S146–S170. https://doi.org/10.1093/toxsci/kfq358

    Article  CAS  PubMed  Google Scholar 

  6. Pontillo C, Mischak H (2017) Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease. Clin Kidney J 10(2):192–201. https://doi.org/10.1093/ckj/sfx002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fry CH, Sahai A, Vahabi B, Kanai AJ, Birder LA (2014) What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013. Neurourol Urodyn 33:602–605. https://doi.org/10.1002/nau.22558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mitsui T, Kira S, Ihara T et al (2018) Metabolomics approach to male lower urinary tract symptoms: identification of possible biomarkers and potential targets for new treatments. J Urol 199:1312–1318. https://doi.org/10.1016/j.juro.2017.11.070

    Article  CAS  PubMed  Google Scholar 

  9. Liu Y, Qing H, Deng Y (2014) Biomarkers in Alzheimer’s disease analysis by mass spectrometry-based proteomics. Int J Mol Sci 15:7865–7882. https://doi.org/10.3390/ijms15057865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kira S, Mitsui T, Miyamoto T et al (2018) Lack of change in adaptation ability of the bladder for urine production rate in aged men with nocturia. Urol Int 100:445–449. https://doi.org/10.1159/000488002

    Article  PubMed  Google Scholar 

  11. Kira S, Mitsui T, Miyamoto T et al (2019) Liquid chromatography–mass spectrometry identification of serum biomarkers for nocturia in aged men. World J Urol. https://doi.org/10.1007/s00345-019-02647-4

    Article  PubMed  Google Scholar 

  12. Weiss JP, Blaivas JG, Blanker MH et al (2013) The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int 111(5):700–716. https://doi.org/10.1111/j.1464-410X.2012.11749.x

    Article  PubMed  Google Scholar 

  13. Strassburg K, Huijbrechts AM, Kortekaas KA et al (2012) Quantitative profiling of oxylipins through comprehensive LC–MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem 404:1413–1426. https://doi.org/10.1007/s00216-012-6226-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Audhya T, Adams JB, Johansen L (2012) Correlation of serotonin levels in CSF, platelets, plasma, and urine. Biochim Biophys Acta 1820:1496–1501. https://doi.org/10.1016/j.bbagen.2012.05.012

    Article  CAS  PubMed  Google Scholar 

  15. Asplund R, Johansson S, Henriksson S, Isacsson G (2005) Nocturia, depression and antidepressant medication. BJU Int 95:820–823. https://doi.org/10.1111/j.1464-410X.2005.05408.x

    Article  PubMed  Google Scholar 

  16. Ramage AG (2006) The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition. Br J Pharmacol 147:S120–S131. https://doi.org/10.1038/sj.bjp.0706504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ishizuka O, Gu B, Igawa Y, Nishizawa O, Pehrson R, Andersson KE (2002) Role of supraspinal serotonin receptors for micturition in normal conscious rats. Neurourol Urodyn 21:225–230

    Article  CAS  Google Scholar 

  18. Young SN (2007) How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci 32:394–399

    PubMed  PubMed Central  Google Scholar 

  19. Versteeg RI, Serlie MJ, Kalsbeek A, la Fleur SE (2015) Serotonin, a possible intermediate between disturbed circadian rhythms and metabolic disease. Neuroscience 301:155–167. https://doi.org/10.1016/j.neuroscience.2015.05.067

    Article  CAS  PubMed  Google Scholar 

  20. Andersson KE, Van Kerrebroeck P (2018) Pharmacotherapy for nocturia. Curr Urol Rep 19:8. https://doi.org/10.1007/s11934-018-0750-y

    Article  PubMed  PubMed Central  Google Scholar 

  21. Aoki Y, Yokoyama O (2012) Metabolic syndrome and nocturia. Low Urin Tract Symptoms 4:11–15. https://doi.org/10.1111/j.1757-5672.2011.00118.x

    Article  PubMed  Google Scholar 

  22. Konopelski P, Ufnal M (2018) Indole-gut bacteria metabolites of tryptophan with pharmacotherapeutic potential. Curr Drug Metab 19:883–890. https://doi.org/10.2174/1389200219666180427164731

    Article  CAS  PubMed  Google Scholar 

  23. Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23:716–724. https://doi.org/10.1016/j.chom.2018.05.003

    Article  CAS  PubMed  Google Scholar 

  24. Kupelian V, McVary KT, Kaplan SA et al (2009) Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol 182:616–625. https://doi.org/10.1016/j.juro.2012.11.026

    Article  PubMed  PubMed Central  Google Scholar 

  25. Takeuchi K, Toyohara H, Sakaguchi M (2000) A hyperosmotic stress-induced mRNA of carp cell encodes Na(+)- and Cl(−)-dependent high affinity taurine transporter. Biochim Biophys Acta 1464:219–230. https://doi.org/10.1016/s0005-2736(00)00158-9

    Article  CAS  PubMed  Google Scholar 

  26. Hoffman JR, Ostfeld I, Stout JR, Harris RC, Kaplan Z, Cohen H (2015) β-Alanine supplemented diets enhance behavioral resilience to stress exposure in an animal model of PTSD. Amino Acids 47:1247–1257. https://doi.org/10.1007/s00726-015-1952-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen G, Yang D, Yang Y et al (2015) Amino acid metabolic dysfunction revealed in the prefrontal cortex of a rat model of depression. Behav Brain Res 278:286–292. https://doi.org/10.1016/j.bbr.2014.05.027

    Article  CAS  PubMed  Google Scholar 

  28. Breyer BN, Shindel AW, Erickson BA et al (2013) The association of depression, anxiety and nocturia: a systematic review. J Urol 190:953–957. https://doi.org/10.1016/j.bbr.2014.05.027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was funded by Astellas Pharma, Inc. and designed by Astellas Pharma, Inc. in collaboration with the authors.

Funding

This study was funded by Astellas Pharma, Inc.

Author information

Authors and Affiliations

  1. Department of Urology Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Yamanashi, Japan

    Satoru Kira, Takahiko Mitsui, Tatsuya Miyamoto, Tatsuya Ihara, Hiroshi Nakagomi, Sachiko Tsuchiya, Norifumi Sawada & Masayuki Takeda

  2. Pharmacology Research Labs, Astellas Pharma Inc, Tsukuba-shi, Japan

    Yuka Hashimoto, Hajime Takamatsu, Masayuki Tanahashi & Masahiro Takeda

Authors
  1. Satoru Kira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takahiko Mitsui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tatsuya Miyamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tatsuya Ihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Nakagomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuka Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hajime Takamatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masayuki Tanahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masahiro Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sachiko Tsuchiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Norifumi Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Masayuki Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SK: data collection, data analysis, manuscript writing. TM: data analysis, manuscript editing. TM: data collection, data analysis. TI: data analysis. HN: data collection, data analysis. YH: data analysis. HT: data analysis. MT: data analysis. MT: data analysis, other (supervision). ST: data management. NS: data analysis. MT: data analysis manuscript editing, other (supervision).

Corresponding author

Correspondence to Satoru Kira.

Ethics declarations

Conflict of interest

The study was designed by Astellas Pharma, Inc. in collaboration with the authors. Several of the authors are employees of Astellas Pharma, Inc. The other authors have no potential competing interests to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kira, S., Mitsui, T., Miyamoto, T. et al. Urinary metabolites identified using metabolomic analysis as potential biomarkers of nocturia in elderly men. World J Urol 38, 2563–2569 (2020). https://doi.org/10.1007/s00345-019-03042-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-019-03042-9

Keywords

Search

Navigation